Sponsor

TJ Biopharma Co., Ltd.

Clinical research sponsor

Published trials4

Recruiting shown0

Roles1

SourceClinicalTrials.gov

Clinical trials

4 shown

A Study to Compare Uliledlimab Combined With Sintilimab and Chemotherapy Versus Sintilimab Combined With Chemotherapy in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic Non-small Cell Lung CancerNCT07005336 · lead sponsor · 2025-01-09

ACTIVE_NOT_RECRUITING

A Study to Compare Uliledlimab Combined With Toripalimab, Toripalimab Monotherapy, and Pembrolizumab Monotherapy in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1- and CD73- Selected Non-Small Cell Lung CancerNCT06984588 · lead sponsor · 2024-03-28

ACTIVE_NOT_RECRUITING

Clinical Trial of TJ271 Injection Combined With Pembrolizumab in the Treatment of Advanced Solid TumorsNCT05338580 · lead sponsor · 2023-12-31

WITHDRAWN

Study to Evaluate Safety and Efficacy of TJ107 Combine With PD-1 in Patients With Solid TumorsNCT05145907 · lead sponsor · 2021-12-22

UNKNOWN

Sponsor roles

lead sponsor4

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.